Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Von Hoff

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|August 8, 2015
ResponseDavid Goldstein, Daniel Von Hoff
Cell|February 27, 2016
Hedgehog Pathway InhibitionAleksandar Sekulic, Daniel Von Hoff
The Oncologist|March 19, 2022
In ReplyDaniel Von Hoff, Derek Cridebring, Haiyong Han
World Journal of Gastroenterology|March 29, 2017
Microbiome and pancreatic cancer: A comprehensive topic review of literatureNatalie Ertz-Archambault, Paul Keim, Daniel Von Hoff
Frontiers in Oncology|September 28, 2020
GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor SignalingLaurence Booth, Cameron West, Daniel Von Hoff, et al.
Anti-Cancer Drugs|March 11, 2022
Mechanisms of GZ17-6.02 resistanceLaurence Booth, Cameron West, Daniel Von Hoff, et al.
Frontiers in Oncology|May 3, 2021
Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells <i>via</i> Autophagy and Death Receptor SignalingLaurence Booth, Cameron West, Daniel Von Hoff, et al.
Seminars in Cancer Biology|October 13, 2020
Non-coding RNA biomarkers in pancreatic ductal adenocarcinomaGeeta G Sharma, Yasuyuki Okada, Daniel Von Hoff, et al.
Cancers|June 14, 2020
Extracellular Vesicles in Diagnosis and Treatment of Pancreatic Cancer: Current State and Future PerspectivesJ Spencer Lane, Daniel Von Hoff, Derek Cridebring, et al.
Seminars in Cancer Biology|January 25, 2022
Corrigendum to "Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma" [Semin. Cancer Biol. 75 (2021) 153-168]Geeta G Sharma, Yasuyuki Okada, Daniel Von Hoff, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|August 8, 2015
ResponseDavid Goldstein, Daniel Von Hoff
Cell|February 27, 2016
Hedgehog Pathway InhibitionAleksandar Sekulic, Daniel Von Hoff
The Oncologist|March 19, 2022
In ReplyDaniel Von Hoff, Derek Cridebring, Haiyong Han
World Journal of Gastroenterology|March 29, 2017
Microbiome and pancreatic cancer: A comprehensive topic review of literatureNatalie Ertz-Archambault, Paul Keim, Daniel Von Hoff
Frontiers in Oncology|September 28, 2020
GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor SignalingLaurence Booth, Cameron West, Daniel Von Hoff, et al.
Anti-Cancer Drugs|March 11, 2022
Mechanisms of GZ17-6.02 resistanceLaurence Booth, Cameron West, Daniel Von Hoff, et al.
Frontiers in Oncology|May 3, 2021
Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells <i>via</i> Autophagy and Death Receptor SignalingLaurence Booth, Cameron West, Daniel Von Hoff, et al.
Seminars in Cancer Biology|October 13, 2020
Non-coding RNA biomarkers in pancreatic ductal adenocarcinomaGeeta G Sharma, Yasuyuki Okada, Daniel Von Hoff, et al.
Cancers|June 14, 2020
Extracellular Vesicles in Diagnosis and Treatment of Pancreatic Cancer: Current State and Future PerspectivesJ Spencer Lane, Daniel Von Hoff, Derek Cridebring, et al.
Seminars in Cancer Biology|January 25, 2022
Corrigendum to "Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma" [Semin. Cancer Biol. 75 (2021) 153-168]Geeta G Sharma, Yasuyuki Okada, Daniel Von Hoff, et al.
Pageof 8